1. Wong GLH, Gane E, Lok ASF. How to achieve functional cure of HBV: stopping NUCs, adding interferon or new drug development? J Hepatol 2022. 76:1249-1262.
2. Yip TCF, Wong GLH, Chan HLY, Tse YK, Lam KLY, Lui GCY, et al. HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues. J Hepatol 2019. 70:361-370.
3. Yip TC, Wong VW, Tse YK, Chan HL, Wong GL. Hepatitis B surface antigen seroclearance in a cohort of 154,740 patients with chronic hepatitis B: a 15-year follow-up study. Hepatol Int 2017. 11(Suppl 1):S75.
7. Mak LY, Wong D, Kuchta A, Hilfiker M, Hamilton A, Chow N, et al. Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers. Clin Mol Hepatol 2023. 29:146-162.
8. Wang J, Shen T, Huang X, Kumar GR, Chen X, Zeng Z, et al. Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound. J Hepatol 2016. 65:700-710.
11. Cornberg M, Lok AS, Terrault NA, Zoulim F; 2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡. J Hepatol 2020. 72:539-557.
15. Sonneveld MJ, Chiu SM, Park JY, Brakenhoff SM, Kaewdech A, Seto WK, et al. Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels. J Hepatol 2022. 76:1042-1050.
16. Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, et al. HBcrAg predicts hepatocellular carcinoma development: an analysis using time-dependent receiver operating characteristics. J Hepatol 2016. 65:48-56.
18. Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, et al. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology 2012. 142:1140-1149.
19. Yip TCF, Lok ASF. How do we determine whether a functional cure for HBV infection has been achieved? Clin Gastroenterol Hepatol 2020. 18:548-550.